Iovance Biotherapeutics (IOVA) Stock: Buy, Sell, or Hold?
IOVA - Iovance Biotherapeutics, Inc. Common Stock
$8.60
0.46 (5.65%)
â˛
5d:
-1.15%
30d:
+27.6%
90d:
+117.17%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Nov 05, 2026
Smart Money Accumulation
Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →
Signal fired Sep 9, 2026 at $8.43 · last confirmed Sep 11, 2026
Strength: 5.6/10
Get Alerted When IOVA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: IOVA is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: IOVA is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: IOVA is currently trading at $8.60, which is considered slightly high relative to its 30-day fair value range of $6.09 to $8.77.
Technical Outlook: Technically, IOVA is in a strong uptrend. Immediate support is located at $7.66, while resistance sits at $8.91. The stock is showing strong short-term momentum, up 5.7% recently.
Market Sentiment: IOVA scores 32/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $10.00 (+16.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, IOVA is in a strong uptrend. Immediate support is located at $7.66, while resistance sits at $8.91. The stock is showing strong short-term momentum, up 5.7% recently.
Market Sentiment: IOVA scores 32/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $10.00 (+16.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$6.09 -
$8.77
Company Quality Score
47/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
44.7%
All Signals
- BEARISH: Weak technical setup (32/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+5.7%)
- BULLISH: Trading below Wall St target ($10.00)
- WARNING: Composite score 47/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$6.09 -
$8.77
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$7.66
Resistance Level
$8.91
Current Trend
Strong Uptrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-29.93
Wall Street Target
$10.00
(+16.3%)
Revenue Growth (YoY)
65.7%
Profit Margin
-89.1%
Share & Embed Analysis
Last updated: September 12, 2026 7:39 PM ET
Data refreshes hourly during market hours. Next update: 8:39 PM
Data refreshes hourly during market hours. Next update: 8:39 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IOVA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$432 | 48 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$200 | 54 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$88 | 44 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$110 | 53 HOLD |
|
CRNX
Crinetics PharmaceuticalâĻ |
STRONG BUY
17 analysts |
$86 | 46 HOLD |
